Cite
HARVARD Citation
Hermangild Kottoor, S. et al. (n.d.). PWE-022 Gut-homing TH17 cells are selectively targeted by vedolizumab and may predict clinical response in IBD. Gut. pp. A78-A79. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hermangild Kottoor, S. et al. (n.d.). PWE-022 Gut-homing TH17 cells are selectively targeted by vedolizumab and may predict clinical response in IBD. Gut. pp. A78-A79. [Online].